查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1469796

全球濫用藥物測試市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Drugs of Abuse Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

全球濫用藥物測試市場需求預計將從 2023 年的 69.9 億美元達到 2032 年近 231.5 億美元的市場規模，2024-2032 年研究期間複合年成長率為 14.23%。

濫用藥物檢測是指對生物樣本進行分析，以確定是否有非法藥物或用於非醫療目的的處方藥。進行這些測試是為了監測藥物使用情況，確保遵守戒毒康復計劃，並識別受藥物影響的個人。採用尿液、唾液、血液和頭髮檢測等各種方法來篩檢大麻、古柯鹼、鴉片類藥物、安非他明和苯二氮平類藥物等藥物。該測試對於執法、工作場所安全、醫療保健和成癮治療環境至關重要，以防止藥物濫用、支持康復工作以及維護公共健康和安全。

市場動態

全球藥物濫用盛行率的上升是藥物濫用檢測需求不斷成長的主要動力。各地政府和監管機構正在實施嚴格的法律法規來打擊藥物濫用，從而促進工作場所、執法機構和康復中心採用藥物檢測程序。此外，人們越來越認知到藥物濫用對公共健康和安全的不利影響，並鼓勵雇主、教育機構和醫療機構實施常規藥物檢測計劃。此外，藥物檢測技術的進步，包括快速檢測試劑盒、現場護理設備和基於實驗室的分析技術的開發，提高了藥物濫用檢測的效率、準確性和可靠性，進一步推動了市場成長。此外，擴大診斷實驗室、藥物檢測公司和醫療保健提供者提供的藥物檢測服務以滿足不斷成長的需求有助於市場擴張。

此外，新型精神活性物質的出現和持續的鴉片類藥物流行加劇了對全面、多面板藥物測試解決方案的需求，推動了市場創新。此外，就業前篩檢、體育組織和運輸部門擴大採用藥物檢測來確保安全和遵守法規，這也刺激了市場需求。此外，對工作場所健康計劃和員工健康計劃的日益關注正在推動將藥物測試納入全面健康評估的一部分，進一步推動市場成長。然而，藥物檢測技術的進步和監管變化可能會挑戰未來幾年藥物濫用檢測市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球濫用藥物測試市場的各個細分市場進行了包容性評估。濫用藥物檢測行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

濫用藥物測試市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依產品類型

  • 分析儀（免疫分析儀、層析儀、呼吸分析儀）
  • 快速檢測設備（尿液檢測設備、口腔液檢測設備）
  • 消耗品（液體收集裝置、其他）

依樣品類型

  • 唾液
  • 呼吸
  • 尿
  • 血
  • 頭髮與汗水

按測試類型

  • 疼痛管理測試
  • 刑事司法測試
  • 工作場所篩檢

按最終用戶

  • 醫院
  • 診斷實驗室
  • 現場測試
  • 法醫實驗室

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲濫用藥物測試市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。濫用藥物測試市場的主要參與者包括美國實驗室控股公司、丹納赫公司、雅培、賽默飛世爾科技公司、羅氏公司、西門子醫療、Dragerwerk AG & Co. KGaA、島津公司、 CareHealth America Corp . 本部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：濫用藥物測試 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 市場吸引力分析：按產品類型
    • 按樣本類型進行的市場吸引力分析
    • 按測試類型進行的市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球藥物濫用測試市場分析：按產品類型

  • 概述：按產品類型
  • 歷史和預測數據
  • 分析：依產品類型
  • 分析儀（免疫分析儀、層析儀、呼吸分析儀）
  • 快速檢測設備（尿液檢測設備、口腔液檢測設備）
  • 消耗品（液體收集裝置、其他）

第 6 章：全球藥物濫用測試市場分析：按樣本類型

  • 依樣本類型概述
  • 歷史和預測數據
  • 依樣本類型分析
  • 唾液
  • 呼吸
  • 尿
  • 血
  • 頭髮與汗水

第 7 章：全球濫用藥物測試市場分析：按測試類型

  • 按測試類型概述
  • 歷史和預測數據
  • 按測試類型分析
  • 疼痛管理測試
  • 刑事司法測試
  • 工作場所篩檢

第 8 章：全球藥物濫用測試市場分析：按最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 醫院
  • 診斷實驗室
  • 現場測試
  • 法醫實驗室

第 9 章：全球藥物濫用測試市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：濫用藥物檢測公司的競爭格局

  • 濫用藥物測試市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Laboratory Corporation of America Holdings
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Danaher Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Abbott
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • F. Hoffmann-La Roche Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Siemens Healthineers
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Dragerwerk AG & Co. KGaA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Shimadzu Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • CareHealth America Corp.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112114183

The global demand for Drugs of Abuse Testing Market is presumed to reach the market size of nearly USD 23.15 Billion by 2032 from USD 6.99 Billion in 2023 with a CAGR of 14.23% under the study period 2024 - 2032.

Drugs of abuse testing refers to the analysis of biological samples to identify the existence of illicit drugs or prescription medications used for non-medical purposes. These tests are conducted to monitor drug use, ensure compliance with drug rehabilitation programs, and identify individuals under the influence of drugs. Various methods, such as urine, saliva, blood, and hair testing, are employed to screen for drugs like cannabis, cocaine, opioids, amphetamines, and benzodiazepines. This testing is essential in law enforcement, workplace safety, healthcare, and addiction treatment settings to prevent drug abuse, support rehabilitation efforts, and maintain public health and safety.

MARKET DYNAMICS

The rising prevalence of substance abuse globally is a major driving force behind the increasing demand for drug abuse testing. Governments and regulatory bodies across various regions are implementing stringent laws and regulations to combat drug abuse, thereby boosting the adoption of drug testing procedures in workplaces, law enforcement agencies, and rehabilitation centers. Moreover, the growing awareness regarding the detrimental effects of drug abuse on public health and safety is encouraging employers, educational institutions, and healthcare facilities to implement routine drug testing programs. Additionally, advancements in drug testing technologies, including the development of rapid testing kits, point-of-care devices, and laboratory-based analytical techniques, enhance the efficiency, accuracy, and reliability of drug abuse testing, further driving market growth. Furthermore, expanding drug testing services offered by diagnostic laboratories, drug testing companies, and healthcare providers to cater to the increasing demand contributes to market expansion.

Moreover, the emergence of new psychoactive substances and the ongoing opioid epidemic are fuelling the need for comprehensive and multi-panel drug testing solutions, driving innovation in the market. Additionally, the increasing adoption of drug testing in pre-employment screening, sports organizations, and transportation sectors to ensure safety and compliance with regulations is boosting market demand. Furthermore, the growing focus on workplace wellness programs and employee health initiatives is driving the integration of drug testing as part of comprehensive health assessments, further propelling market growth. However, advancements in drug detection technologies and regulatory changes may challenge the drug abuse testing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drugs of abuse testing. The growth and trends of drugs of abuse testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the drugs of abuse testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers)
  • Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices)
  • Consumables (Fluid Collection Devices, Others)

By Sample Type

  • Saliva
  • Breath
  • Urine
  • Blood
  • Hair & Sweat

By Testing Type

  • Pain Management Testing
  • Criminal Justice Testing
  • Workplace Screening

By End-User

  • Hospitals
  • Diagnostics Laboratories
  • On-The-Spot Testing
  • Forensic Laboratories

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drugs of Abuse Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drugs of Abuse Testing market include Laboratory Corporation of America Holdings, Danaher Corporation, Abbott, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Dragerwerk AG & Co. KGaA, Shimadzu Corporation, CareHealth America Corp. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DRUGS OF ABUSE TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Sample Type
    • 3.7.3 Market Attractiveness Analysis By Testing Type
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1 Overview by Product Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product Type
  • 5.4 Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers) Historic and Forecast Sales by Regions
  • 5.5 Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices) Historic and Forecast Sales by Regions
  • 5.6 Consumables (Fluid Collection Devices, Others) Historic and Forecast Sales by Regions

6 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY SAMPLE TYPE

  • 6.1 Overview by Sample Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Sample Type
  • 6.4 Saliva Historic and Forecast Sales by Regions
  • 6.5 Breath Historic and Forecast Sales by Regions
  • 6.6 Urine Historic and Forecast Sales by Regions
  • 6.7 Blood Historic and Forecast Sales by Regions
  • 6.8 Hair & Sweat Historic and Forecast Sales by Regions

7 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY TESTING TYPE

  • 7.1 Overview by Testing Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Testing Type
  • 7.4 Pain Management Testing Historic and Forecast Sales by Regions
  • 7.5 Criminal Justice Testing Historic and Forecast Sales by Regions
  • 7.6 Workplace Screening Historic and Forecast Sales by Regions

8 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY END-USER

  • 8.1 Overview by End-user
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-user
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Diagnostics Laboratories Historic and Forecast Sales by Regions
  • 8.6 On-the-spot Testing Historic and Forecast Sales by Regions
  • 8.7 Forensic Laboratories Historic and Forecast Sales by Regions

9 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE DRUGS OF ABUSE TESTING COMPANIES

  • 10.1. Drugs Of Abuse Testing Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF DRUGS OF ABUSE TESTING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Laboratory Corporation of America Holdings
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Danaher Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Abbott
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Thermo Fisher Scientific Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. F. Hoffmann-La Roche Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Siemens Healthineers
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Dragerwerk AG & Co. KGaA
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Shimadzu Corporation
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. CareHealth America Corp.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers) Market Sales by Geography (USD MN)
  • Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices) Market Sales by Geography (USD MN)
  • Consumables (Fluid Collection Devices, Others) Market Sales by Geography (USD MN)
  • Analysis Market by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Breath Market Sales by Geography (USD MN)
  • Urine Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Hair & Sweat Market Sales by Geography (USD MN)
  • Analysis by Testing Type (USD MN)
  • Pain Management Testing Market Sales by Geography (USD MN)
  • Criminal Justice Testing Market Sales by Geography (USD MN)
  • Workplace Screening Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostics Laboratories Market Sales by Geography (USD MN)
  • On-the-spot Testing Market Sales by Geography (USD MN)
  • Forensic Laboratories Market Sales by Geography (USD MN)
  • Global Drugs Of Abuse Testing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Drugs Of Abuse Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Drugs Of Abuse Testing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Sample Type
  • Market Attractiveness Analysis by Testing Type
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers) Market Sales by Geography (USD MN)
  • Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices) Market Sales by Geography (USD MN)
  • Consumables (Fluid Collection Devices, Others) Market Sales by Geography (USD MN)
  • Global Market Analysis by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Breath Market Sales by Geography (USD MN)
  • Urine Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Hair & Sweat Market Sales by Geography (USD MN)
  • Global Market Analysis by Testing Type (USD MN)
  • Pain Management Testing Market Sales by Geography (USD MN)
  • Criminal Justice Testing Market Sales by Geography (USD MN)
  • Workplace Screening Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostics Laboratories Market Sales by Geography (USD MN)
  • On-the-spot Testing Market Sales by Geography (USD MN)
  • Forensic Laboratories Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.